← FDA Drug Approvals (Drugs@FDA)
OSMOVIST 240
NDA · New Drug Application · Sponsor: BAYER HLTHCARE
Drug application
- FDA Application #
NDA019580- Application type
- New Drug Application
- Brand name
- OSMOVIST 240
- Generic name
- Iotrolan
- Active ingredients
- IOTROLAN
- Dosage form
- INJECTABLE
- Route
- INTRATHECAL
- Marketing status
- Discontinued
- Sponsor
- BAYER HLTHCARE
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown